The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It ...

Unlike rival CDK 4/6 inhibitor abemaciclib, patients don't need to be lymph-node positive to receive ribociclib after surgery ...

The FDA has approved Kisqali (ribociclib) in adults with HR-positive, HER2-negative stage II and III early breast cancer.

This new indication also applies to Kisqali Femara Co-Pack (ribociclib with letrozole). The approval was based on data from the phase 3 NATALEE trial (NCT03701334), which enrolled 5101 adults with ...

The drug joins abemaciclib (Verzenio) as approved CDK4/6 inhibitors in this setting, but the broader indication for ...

Kisqali has been FDA-approved with an aromatase inhibitor as postsurgical treatment for some with early breast cancer at a ...

The FDA approved ribociclib (Kisqali) for adjuvant treatment of high-risk, hormone receptor-positive, HER2-negative early breast cancer. The FDA approved ribociclib (Kisqali) with an aromatase ...

In addition to this approval, the FDA also approved the ribociclib and letrozole co-pack for the same indication. 1 2. FDA ...

Are you ready to carve out abs of steel and build full-body strength in 30 days? This 30-day workout plan to build a six-pack will do just that—no shortcuts, no gimmicks. We've combined the most ...

I have a list of different ideas I rotate so it’s easy when I do the shopping on weekends. “I pack things that are quick to make, don’t need to be refrigerated and that I know my four-year ...